| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | NEUTRAL | NEUTRAL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.73▼ | 2.72▼ | 2.73▼ | 2.64▼ | 2.49▲ |
| MA10 | 2.73▼ | 2.69▼ | 2.66▼ | 2.54▲ | 3.03▼ |
| MA20 | 2.57▲ | 2.51▲ | 2.48▲ | 2.41▲ | 3.91▼ |
| MA50 | 2.39▲ | 2.40▲ | 2.40▲ | 3.44▼ | 5.49▼ |
| MA100 | 2.77▼ | 3.16▼ | 3.41▼ | 4.14▼ | 4.40▼ |
| MA200 | 3.64▼ | 4.01▼ | 4.14▼ | 5.25▼ | 3.84▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.005▲ | 0.033▲ | 0.047▲ | 0.106▲ | -0.120▼ |
| RSI | 55.086▲ | 56.387▲ | 55.624▲ | 40.087▼ | 31.185▼ |
| STOCH | 56.587 | 70.088 | 77.921 | 65.019 | 10.930▼ |
| WILL %R | -36.342 | -35.386 | -35.386 | -57.528 | -86.136▼ |
| CCI | -14.403 | 26.083 | 34.648 | 33.713 | -67.528 |
|
Wednesday, December 17, 2025 09:05 PM
FRAMINGHAM, Mass., Dec. 18, 2025 /PRNewswire/ -- Pulmatrix, Inc. ("Pulmatrix" or the "Company") (Nasdaq: PULM), a biopharmaceutical company that has focused on the development of novel inhaled ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 26/01/26 | 2.67 | 2.67 | 2.4706 | 2.54 | 11,384 |
| 23/01/26 | 2.61 | 2.86 | 2.60 | 2.6583 | 5,018 |
| 22/01/26 | 2.67 | 2.732 | 2.61 | 2.68 | 8,543 |
| 21/01/26 | 2.68 | 2.9599 | 2.63 | 2.63 | 29,839 |
| 20/01/26 | 2.60 | 2.67 | 2.5001 | 2.67 | 5,686 |
| 16/01/26 | 2.53 | 2.69 | 2.46 | 2.625 | 16,977 |
| 15/01/26 | 2.35 | 2.70 | 2.35 | 2.53 | 32,064 |
| 14/01/26 | 2.32 | 2.4988 | 2.30 | 2.37 | 19,549 |
| 13/01/26 | 2.35 | 2.38 | 2.29 | 2.33 | 7,538 |
| 12/01/26 | 2.38 | 2.5775 | 2.23 | 2.35 | 19,800 |
|
|
||||
|
|
||||
|
|